Works matching IS 01676997 AND DT 2011 AND VI 29 AND IP 6

Results: 55

A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer.

Published in:

2011

By:

Bryan, Margarette;
Pulte, E Dianne;
Toomey, Kathleen C;
Pliner, Lillian;
Pavlick, Anna C;
Saunders, Tracie;
Wieder, Robert

Publication type:

Journal Article

A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal(R) dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC)

Published in:

2011

By:

Harrison, Michael R;
Hahn, Noah M;
Pili, Roberto;
Oh, William K;
Hammers, Hans;
Sweeney, Christopher;
Kim, Kyungmann;
Perlman, Scott;
Arnott, Jamie;
Sidor, Carolyn;
Wilding, George;
Liu, Glenn

Publication type:

Journal Article

A phase I study of the vitamin D(3) analogue ILX23-7553 administered orally to patients with advanced solid tumors.

Published in:

2011

By:

Jain, Rajul K;
Trump, Donald L;
Egorin, Merrill J;
Fernandez, Manuel;
Johnson, Candace S;
Ramanathan, Ramesh K

Publication type:

Journal Article

Protoapigenone, a natural derivative of apigenin, induces mitogen-activated protein kinase-dependent apoptosis in human breast cancer cells associated with induction of oxidative stress and inhibition of glutathione S-transferase [pi].

Published in:

2011

By:

Chen, Wen-Ying;
Hsieh, Yu-An;
Tsai, Ching-I;
Kang, Ya-Fei;
Chang, Fang-Rong;
Wu, Yang-Chang;
Wu, Chin-Chung

Publication type:

Journal Article

Cytostatic activity of the duplex drug linking 2'-deoxy-5-fluorouridine (5FdU) with 3'-C-ethynylcytidine (ECyd) against gastric adenocarcinoma cell lines.

Published in:

2011

By:

Weinreich, Jürgen;
Schott, Sarah;
Königsrainer, Ingmar;
Zieker, Derek;
Königsrainer, Alfred;
Schott, Herbert

Publication type:

Journal Article

Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using (125)I, an Auger electron emitter.

Published in:

2011

By:

Gardette, Maryline;
Papon, Janine;
Bonnet, Mathilde;
Desbois, Nicolas;
Labarre, Pierre;
Wu, Ting-Dee;
Miot-Noirault, Elisabeth;
Madelmont, Jean-Claude;
Guerquin-Kern, Jean-Luc;
Chezal, Jean-Michel;
Moins, Nicole

Publication type:

Journal Article

Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1[alpha] expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells.

Published in:

2011

By:

Weng, Qinjie;
Zhang, Jun;
Cao, Ji;
Xia, Qing;
Wang, Duoduo;
Hu, Yongzhou;
Sheng, Rong;
Wu, Honghai;
Zhu, Difeng;
Zhu, Hong;
He, Qiaojun;
Yang, Bo

Publication type:

Journal Article

Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1432, doi. 10.1007/s10637-010-9420-8

By:

Bradley, Deborah;
Daignault, Stephanie;
Ryan, Charles;
DiPaola, Robert;
Smith, David;
Small, Eric;
Gross, Mitchell;
Stein, Mark;
Chen, Alice;
Hussain, Maha

Publication type:

Article

Oral enzastaurin in prostate cancer: A two-cohort phase II trial in patients with PSA progression in the non-metastatic castrate state and following docetaxel-based chemotherapy for castrate metastatic disease.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1441, doi. 10.1007/s10637-010-9428-0

By:

Dreicer, Robert;
Garcia, Jorge;
Hussain, Maha;
Rini, Brian;
Vogelzang, Nicholas;
Srinivas, Sandy;
Somer, Bradley;
Zhao, Yan;
Kania, Marek;
Raghavan, Derek

Publication type:

Article

Phase II study of sunitinib as second-line treatment for advanced gastric cancer.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1449, doi. 10.1007/s10637-010-9438-y

By:

Bang, Yung-Jue;
Kang, Yoon-Koo;
Kang, Won;
Boku, Narikazu;
Chung, Hyun;
Chen, Jen-Shi;
Doi, Toshihiko;
Sun, Yan;
Shen, Lin;
Qin, Shukui;
Ng, Wai-Tong;
Tursi, Jennifer;
Lechuga, Maria;
Lu, Dongrui;
Ruiz-Garcia, Ana;
Sobrero, Alberto

Publication type:

Article

Activity of topotecan given intravenously for 5 days every three weeks in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes: a phase II study.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1459, doi. 10.1007/s10637-010-9442-2

By:

Gonzalez, Emilio;
Villanueva, Noemi;
Fra, Joaquin;
Berros, Jose;
Jimenez, Paula;
Luque, María;
Muñiz, Isabel;
Blay, Pilar;
Fernandez, Yolanda;
Vieitez, José;
Muriel, Carolina;
Sanmamed, Miguel;
Coto, Pablo;
Izquierdo, Marta;
Estrada, Enrique;
Lacave, Angel

Publication type:

Article

Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1123, doi. 10.1007/s10637-010-9451-1

By:

Hui, Edwin;
Lui, Vivian;
Wong, Cesar;
Ma, Brigette;
Lau, Cecilia;
Cheung, Crystal;
Ho, Kakiu;
Cheng, Suk-hang;
Ng, Margaret;
Chan, Anthony

Publication type:

Article

Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1132, doi. 10.1007/s10637-010-9452-0

By:

Beljanski, Vladimir;
Knaak, Christian;
Zhuang, Yan;
Smith, Charles

Publication type:

Article

LQB-118, a pterocarpanquinone structurally related to lapachol [2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone]: a novel class of agent with high apoptotic effect in chronic myeloid leukemia cells.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1143, doi. 10.1007/s10637-010-9453-z

By:

Maia, Raquel;
Vasconcelos, Flavia;
Sá Bacelar, Thiago;
Salustiano, Eduardo;
Silva, Luis;
Pereira, Débora;
Moellman-Coelho, Arthur;
Netto, Chaquip;
Silva, Alcides;
Rumjanek, Vivian;
Costa, Paulo

Publication type:

Article

A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC).

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1465, doi. 10.1007/s10637-010-9455-x

By:

Harrison, Michael;
Hahn, Noah;
Pili, Roberto;
Oh, William;
Hammers, Hans;
Sweeney, Christopher;
Kim, KyungMann;
Perlman, Scott;
Arnott, Jamie;
Sidor, Carolyn;
Wilding, George;
Liu, Glenn

Publication type:

Article

Dequalinium induces apoptosis in peripheral blood mononuclear cells isolated from human chronic lymphocytic leukemia.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1156, doi. 10.1007/s10637-010-9454-y

By:

Pajuelo, Lucia;
Calviño, Eva;
Diez, Jose;
Boyano-Adánez, Maria del;
Gil, Juana;
Sancho, Pilar

Publication type:

Article

Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1177, doi. 10.1007/s10637-010-9462-y

By:

Weng, Qinjie;
Zhang, Jun;
Cao, Ji;
Xia, Qing;
Wang, Duoduo;
Hu, Yongzhou;
Sheng, Rong;
Wu, Honghai;
Zhu, Difeng;
Zhu, Hong;
He, Qiaojun;
Yang, Bo

Publication type:

Article

Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1198, doi. 10.1007/s10637-010-9464-9

By:

Taguchi, Fumiko;
Kodera, Yasuo;
Katanasaka, Yasufumi;
Yanagihara, Kazuyoshi;
Tamura, Tomohide;
Koizumi, Fumiaki

Publication type:

Article

The histone deacetylase inhibitor panobinostat demonstrates marked synergy with conventional chemotherapeutic agents in human ovarian cancer cell lines.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1224, doi. 10.1007/s10637-010-9467-6

By:

Budman, Daniel;
Tai, Julia;
Calabro, Anthony;
John, Veena

Publication type:

Article

The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1206, doi. 10.1007/s10637-010-9465-8

By:

Tong, Wei-Gang;
Estrov, Zeev;
Wang, Yongtao;
O'Brien, Susan;
Faderl, Stefan;
Harris, David;
Pham, Quin;
Hazan-Halevy, Inbal;
Liu, Zhiming;
Koch, Patricia;
Kantarjian, Hagop;
Keating, Michael;
Ferrajoli, Alessandra

Publication type:

Article

Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1164, doi. 10.1007/s10637-010-9461-z

By:

Moretto, Johnny;
Chauffert, Bruno;
Ghiringhelli, François;
Aldrich-Wright, Janice;
Bouyer, Florence

Publication type:

Article

Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using I, an Auger electron emitter.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1253, doi. 10.1007/s10637-010-9471-x

By:

Gardette, Maryline;
Papon, Janine;
Bonnet, Mathilde;
Desbois, Nicolas;
Labarre, Pierre;
Wu, Ting-Dee;
Miot-Noirault, Elisabeth;
Madelmont, Jean-Claude;
Guerquin-Kern, Jean-Luc;
Chezal, Jean-Michel;
Moins, Nicole

Publication type:

Article

Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1213, doi. 10.1007/s10637-010-9466-7

By:

Zanella, Alessandro;
Gandin, Valentina;
Porchia, Marina;
Refosco, Fiorenzo;
Tisato, Francesco;
Sorrentino, Francesca;
Scutari, Guido;
Rigobello, Maria;
Marzano, Cristina

Publication type:

Article

Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1241, doi. 10.1007/s10637-010-9470-y

By:

Lui, Vivian;
Lau, Cecilia;
Ho, KaKiu;
Ng, Margaret;
Cheng, Suk;
Tsao, Sai-Wah;
Tsang, Chi;
Lei, Kenny;
Chan, Anthony;
Mok, Tony

Publication type:

Article

A phase I study of topotecan and gemcitabine in advanced solid tumors.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1390, doi. 10.1007/s10637-010-9480-9

By:

Serna, Derek;
Bekaii-Saab, Tanios;
Kraut, Eric

Publication type:

Article

A multicenter, phase II study of Bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1475, doi. 10.1007/s10637-010-9474-7

By:

Shah, Manish;
Power, Derek;
Kindler, Hedy;
Holen, Kyle;
Kemeny, Margaret;
Ilson, David;
Tang, Laura;
Capanu, Marinela;
Wright, John;
Kelsen, David

Publication type:

Article

Anti-tumour effects of xanthone derivatives and the possible mechanisms of action.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1230, doi. 10.1007/s10637-010-9468-5

By:

Su, Quan-Guan;
Liu, Yan;
Cai, Yu-Chen;
Sun, Yue-Li;
Wang, Bo;
Xian, Li-Jian

Publication type:

Article

Influence of mild and moderate hepatic impairment on axitinib pharmacokinetics.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1370, doi. 10.1007/s10637-010-9477-4

By:

Tortorici, Michael;
Toh, Melvin;
Rahavendran, S.;
LaBadie, Robert;
Alvey, Christine;
Marbury, Thomas;
Fuentes, Ernesto;
Green, Matthew;
Ni, Grace;
Hee, Brian;
Pithavala, Yazdi

Publication type:

Article

Cytostatic activity of the duplex drug linking 2′-deoxy-5-fluorouridine (5FdU) with 3′-C-ethynylcytidine (ECyd) against gastric adenocarcinoma cell lines.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1294, doi. 10.1007/s10637-010-9483-6

By:

Weinreich, Jürgen;
Schott, Sarah;
Königsrainer, Ingmar;
Zieker, Derek;
Königsrainer, Alfred;
Schott, Herbert

Publication type:

Article

A pilot phase II trial of all- trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1482, doi. 10.1007/s10637-010-9478-3

By:

Bryan, Margarette;
Pulte, E.;
Toomey, Kathleen;
Pliner, Lillian;
Pavlick, Anna;
Saunders, Tracie;
Wieder, Robert

Publication type:

Article

Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and Myc.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1188, doi. 10.1007/s10637-010-9463-x

By:

Zhen, Hong-Ying;
He, Qi-Hua;
Zhen, Yong-Zhan;
Wang, Shu-Ling;
Liu, Yi-Nan;
Wu, Wei-Hua;
Zhang, Xiao-Yan;
Lu, Ai-Li;
Shen, Li

Publication type:

Article

Modulation of P-gp expression by lapatinib.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1284, doi. 10.1007/s10637-010-9482-7

By:

Dunne, Gráinne;
Breen, Laura;
Collins, Denis;
Roche, Sandra;
Clynes, Martin;
O'Connor, Robert

Publication type:

Article

Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1488, doi. 10.1007/s10637-010-9485-4

By:

Sasaki, Takashi;
Isayama, Hiroyuki;
Nakai, Yousuke;
Mizuno, Suguru;
Yamamoto, Keisuke;
Yagioka, Hiroshi;
Yashima, Yoko;
Kawakubo, Kazumichi;
Kogure, Hirofumi;
Togawa, Osamu;
Matsubara, Saburo;
Sasahira, Naoki;
Hirano, Kenji;
Tsujino, Takeshi;
Tada, Minoru;
Omata, Masao;
Koike, Kazuhiko

Publication type:

Article

The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1276, doi. 10.1007/s10637-010-9481-8

By:

Lu, Jin-Jian;
Chen, Si-Meng;
Zhang, Xiao-Wei;
Ding, Jian;
Meng, Ling-Hua

Publication type:

Article

Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1395, doi. 10.1007/s10637-010-9484-5

By:

LoRusso, Patricia;
Shields, Anthony;
Gadgeel, Shirish;
Vaishampayan, Ulka;
Guthrie, Tina;
Puchalski, Thomas;
Xu, John;
Liu, Qi

Publication type:

Article

Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1264, doi. 10.1007/s10637-010-9475-6

By:

Servida, Federica;
Lecis, Daniele;
Scavullo, Cinzia;
Drago, Carmelo;
Seneci, Pierfausto;
Carlo-Stella, Carmelo;
Manzoni, Leonardo;
Polli, Elio;
Lambertenghi Deliliers, Giorgio;
Delia, Domenico;
Onida, Francesco

Publication type:

Article

Nature and subjectivity of dose-limiting toxicities in contemporary phase 1 trials: comparison of cytotoxic versus non-cytotoxic drugs.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1414, doi. 10.1007/s10637-010-9490-7

By:

Penel, Nicolas;
Adenis, Antoine;
Clisant, Stéphanie;
Bonneterre, Jacques

Publication type:

Article

Reactivation of tuberculosis during temsirolimus therapy.

Published in:

2011

By:

Coriat, Romain;
Mir, Olivier;
Ropert, Stanislas;
Loulergue, Pierre;
Billemont, Bertrand;
Goldwasser, François

Publication type:

Report

Phase I study of weekly plitidepsin as 1-hour infusion combined with carboplatin in patients with advanced solid tumors or lymphomas.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1406, doi. 10.1007/s10637-010-9488-1

By:

Salazar, Ramón;
Plummer, Ruth;
Oaknin, Ana;
Robinson, Angela;
Pardo, Beatriz;
Soto-Matos, Arturo;
Yovine, Alejandro;
Szyldergemajn, Sergio;
Calvert, Alan

Publication type:

Article

Pankiller effect of prolonged exposure to menadione on glioma cells: potentiation by vitamin C.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1314, doi. 10.1007/s10637-010-9489-0

By:

Vita, Marina;
Nagachar, Nivedita;
Avramidis, Dimitrios;
Delwar, Zahid;
Cruz, Mabel;
Siden, Åke;
Paulsson, Kajsa;
Yakisich, Juan

Publication type:

Article

Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1303, doi. 10.1007/s10637-010-9486-3

By:

Buontempo, Francesca;
Ersahin, Tulin;
Missiroli, Silvia;
Senturk, Serif;
Etro, Daniela;
Ozturk, Mehmet;
Capitani, Silvano;
Cetin-Atalay, Rengul;
Neri, Maria

Publication type:

Article

Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1381, doi. 10.1007/s10637-010-9479-2

By:

Garrett, Christopher;
Coppola, Domenico;
Wenham, Robert;
Cubitt, Christopher;
Neuger, Anthony;
Frost, Timothy;
Lush, Richard;
Sullivan, Daniel;
Cheng, Jin;
Sebti, Saïd

Publication type:

Article

Cellular uptake and cytoplasm / DNA distribution of cisplatin and oxaliplatin and their liposomal formulation in human colorectal cancer cell HCT116.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1321, doi. 10.1007/s10637-010-9494-3

By:

Tippayamontri, Thititip;
Kotb, Rami;
Paquette, Benoit;
Sanche, Léon

Publication type:

Article

A phase I study of the vitamin D analogue ILX23-7553 administered orally to patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1420, doi. 10.1007/s10637-010-9492-5

By:

Jain, Rajul;
Trump, Donald;
Egorin, Merrill;
Fernandez, Manuel;
Johnson, Candace;
Ramanathan, Ramesh

Publication type:

Article

VEGF pathway inhibition by anticancer agent sunitinib and susceptibility to atherosclerosis plaque disruption.

Published in:

2011

By:

Ropert, Stanislas;
Vignaux, Olivier;
Mir, Olivier;
Goldwasser, François

Publication type:

Report

Sonodynamic and photodynamic mechanisms of action of the novel hypocrellin sonosensitizer, SL017: mitochondrial cell death is attenuated by 11, 12-epoxyeicosatrienoic acid.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1328, doi. 10.1007/s10637-010-9495-2

By:

El-Sikhry, Haitham;
Miller, Gerald;
Madiyalakan, Madi;
Seubert, John

Publication type:

Article

Bevacizumab-induced small bowel perforation in a patient with breast cancer without intraabdominal metastases.

Published in:

2011

By:

Lecarpentier, Edouard;
Ouaffi, Lamia;
Mir, Olivier;
Berveiller, Paul;
Maurel, Melinda;
Pujade-Lauraine, Eric;
Bouillot, Jean;
Veyrie, Nicolas

Publication type:

Report

YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1337, doi. 10.1007/s10637-010-9496-1

By:

Hung, Chin-Chuan;
Liou, Horng-Huei

Publication type:

Article

A phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignancies.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1426, doi. 10.1007/s10637-010-9498-z

By:

Heath, Elisabeth;
LoRusso, Patricia;
Ramalingam, Suresh;
Awada, Ahmad;
Egorin, Merrill;
Besse-Hamer, Tatiana;
Cardoso, Fatima;
Valdivieso, Manuel;
Has, Teresa;
Alland, Leila;
Zhou, Xiaofei;
Belani, Chandra

Publication type:

Article

Protoapigenone, a natural derivative of apigenin, induces mitogen-activated protein kinase-dependent apoptosis in human breast cancer cells associated with induction of oxidative stress and inhibition of glutathione S-transferase π.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1347, doi. 10.1007/s10637-010-9497-0

By:

Chen, Wen-Ying;
Hsieh, Yu-An;
Tsai, Ching-I;
Kang, Ya-Fei;
Chang, Fang-Rong;
Wu, Yang-Chang;
Wu, Chin-Chung

Publication type:

Article